SCHEMBL6555523

SCHEMBL6555523

CCOc1cc(Cc2cnc(N)nc2N)cc(OCCc2scnc2C)c1-c1ccc(O)cc1

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHFR P00374 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6555576 0.89 DHFR (0.46) DHFR
SCHEMBL6556693 0.85 DHFR (0.61) DHFR
SCHEMBL6555137 0.81 DHFR (0.48) DHFR
SCHEMBL6555447 0.80 DHFR (0.50) DHFR
SCHEMBL6555471 0.79 LMNA (0.54) DHFR
SCHEMBL6555187 0.79 DHFR (0.53) DHFR
SCHEMBL6556812 0.78 DHFR (0.53) DHFR
SCHEMBL6555401 0.78 DHFR (0.62) DHFR
SCHEMBL7040898 0.78 DHFR (0.61) DHFR
SCHEMBL6555453 0.78 DHFR (0.56) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230224-B1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2004-12-29 EP disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed